Osmotica Pharmaceuticals plc to Provide First Quarter 2020 Business and Financial Update on May 12, 2020

Rhea-AI Summary

Osmotica Pharmaceuticals (Nasdaq: OSMT) will release its first quarter financial results for 2020 on May 12, 2020, after U.S. markets close. The executive team, including CEO Brian Markison, COO JD Schaub, and CFO Andrew Einhorn, will host a conference call at 4:30 p.m. ET, accessible via toll-free lines and a webcast. The company focuses on developing and commercializing specialty products for underserved patient populations, with operations in the U.S., Argentina, and Hungary.

Positive

• Scheduled financial results release may indicate progress or stability in operations.
• Focus on specialty products could highlight growth potential in underserved markets.

Negative

• None.

News Market Reaction – OSMT

+0.24%

+0.24% Session move

In the trading session that priced this news, OSMT gained 0.24%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BRIDGEWATER, N.J., May 08, 2020 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, today announced that the Company will release its 2020 first quarter financial results on Tuesday, May 12, 2020, after the close of the U.S. financial markets.

Brian Markison, Chief Executive Officer, James “JD” Schaub, Chief Operating Officer, and Andrew Einhorn, Chief Financial Officer, will host a conference call as follows:

Date Time Toll free (U.S.) International Conference ID Webcast (live and replay)		Tuesday, May 12, 2020   4:30 p.m. ET (866) 672-5029 (409) 217-8312 5646947 www.osmotica.com under the “Investor & News” section

About Osmotica Pharmaceuticals plc

Osmotica Pharmaceuticals plc is a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations. Vertical Pharmaceuticals, LLC represents the Company’s diversified branded portfolio and Trigen Laboratories, LLC represents the non-promoted products including complex generic formulations.

Osmotica has operations in the United States, Argentina, and Hungary.

Investor and Media Relations for Osmotica Pharmaceuticals plc
Lisa M. Wilson
In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com

FAQ

When will Osmotica Pharmaceuticals release its first quarter financial results for 2020?

Osmotica Pharmaceuticals will release its first quarter financial results on May 12, 2020.

What time is the Osmotica Pharmaceuticals conference call scheduled?

The conference call is scheduled for 4:30 p.m. ET on May 12, 2020.

Who will be hosting the Osmotica Pharmaceuticals conference call?

The conference call will be hosted by CEO Brian Markison, COO JD Schaub, and CFO Andrew Einhorn.

How can I access the Osmotica Pharmaceuticals conference call?

You can access the conference call via toll-free numbers or through a webcast available on their website.

What markets does Osmotica Pharmaceuticals operate in?

Osmotica Pharmaceuticals has operations in the United States, Argentina, and Hungary.